In the complex journey of breast cancer treatment, the decision-making process surrounding post-mastectomy breast reconstruction is often fraught with anxiety, technical complexity, and personal uncertainty. While medical advancements have provided patients with an array of reconstructive options, the integration of patient values into these clinical decisions remains a critical challenge.
A landmark study published in the September issue of Plastic and Reconstructive Surgery—the official medical journal of the American Society of Plastic Surgeons (ASPS)—is now shedding new light on this process, specifically focusing on the preferences of African American women. By utilizing innovative decision-science tools, researchers are working to bridge the communication gap between patients and surgeons, ensuring that treatment paths align more closely with the personal values of those undergoing life-altering procedures.
The Core Findings: What Drives Decision-Making?
The research, led by Dr. Ronnie L. Shammas of Memorial Sloan Kettering Cancer Center, in collaboration with experts from Duke University and the University of North Carolina, centers on a core objective: understanding how African American patients navigate the choice between implant-based reconstruction and autologous (tissue-flap) reconstruction.
The study, which surveyed 181 African American women—many of whom were facing mastectomies due to breast cancer or high-genetic risk—found that the risk of major complications is the paramount concern for this patient population. In the hierarchy of patient priorities, the risk of complications accounted for a 26% relative importance factor in their decision-making. The aesthetic appearance of the reconstructed breast followed at 15%.
These findings suggest that while the physical outcome is significant, the fear of morbidity and the reality of a lengthy recovery process weigh heavily on patients’ minds. Interestingly, 85% of the study participants expressed a preference for implant-based reconstruction, a choice frequently associated with patients who report better overall health status and fewer pre-existing comorbidities.
A New Methodology: Adaptive Choice-Based Conjoint (ACBC) Analysis
To extract these nuanced preferences, the research team employed an interactive methodology known as Adaptive Choice-Based Conjoint (ACBC) analysis. Unlike traditional surveys that ask patients to rank static lists of concerns, ACBC provides a simulated environment.
In this study, the tool presented participants with detailed information regarding expected outcomes, potential risks, and recovery times for both implant-based and autologous reconstruction. Crucially, the survey incorporated actual patient photographs. These visuals provided a realistic expectation of the potential scarring and the aesthetic variations of the reconstructed breast.
By presenting these scenarios, the tool allowed researchers to observe how women weighed trade-offs. For example, the 15% of women who opted for autologous reconstruction (using their own tissue, typically from the abdomen) demonstrated a clear willingness to accept specific risks. The data revealed a "threshold of tolerance": these patients were willing to accept up to an 8% increase in major complication risk and a 6% increase in risk to abdominal well-being. If the projected risks exceeded these levels, these patients indicated they would pivot to the safer, less invasive, or more familiar option of implant-based reconstruction.
Chronology: The Evolution of Shared Decision-Making
The push for "shared decision-making" is not new, but its application in plastic surgery has seen a marked evolution over the last two decades.
- Early 2000s: Clinical focus primarily centered on surgical outcomes and oncological safety. Patient preference was often secondary to the surgeon’s recommendation.
- 2010–2015: The rise of patient-reported outcome measures (PROMs) began to shift the conversation. Medical literature started highlighting the disparity in patient satisfaction rates across different racial and socioeconomic groups.
- 2018–2022: Studies began to show that approximately 20% of all breast reconstruction patients felt they had inadequate discussions with their surgical teams. Research suggested this gap was significantly wider for non-White patients, pointing to systemic failures in communication.
- 2024–2025: The current study by Dr. Shammas and his colleagues represents the latest frontier: applying sophisticated decision-science technology directly to the clinical consultation process for historically marginalized groups.
Official Perspectives: The Clinical Imperative
The authors of the study emphasize that the need for better tools is not merely academic—it is a moral and clinical necessity.
"Especially in light of policies emphasizing shared decision-making between patients and physicians, our findings highlight the need for tools to elicit treatment preferences and the importance of discussing treatment goals and preferences," says lead author Dr. Ronnie L. Shammas.
The senior author, Dr. Clara N. Lee of the University of North Carolina, underscores that this study is one of the first to specifically focus on the African American demographic, a group often underrepresented in plastic surgery research. By formally engaging these patients, the researchers hope to validate the patient’s voice in the surgical suite.
"We hope that this method can translate to the improved communication of patient values to the physician, and better inform a shared treatment decision," Dr. Shammas added. The study team noted that two-thirds of the participants found the ACBC exercise "very or extremely helpful," suggesting that patients are not just willing to participate in these complex evaluations—they are actively seeking them out.
Implications for Healthcare Policy and Practice
The implications of this research are far-reaching for oncology, plastic surgery, and hospital administration.
1. Bridging the Disparity Gap
Historically marginalized groups often report lower rates of involvement in their own treatment decisions. By implementing tools like ACBC, hospitals can standardize the way information is presented, ensuring that all patients—regardless of background—receive a comprehensive, data-driven explanation of their options. This "active engagement" model can act as a buffer against the implicit biases that can sometimes affect the physician-patient relationship.
2. Tailoring the Clinical Workflow
The findings suggest that surgeons should not assume a "one-size-fits-all" approach to counseling. Because African American women in this study prioritized complication risks so heavily, clinicians should prioritize transparent, accessible data on surgical risks early in the consultation process. This allows the patient to navigate the "trade-offs" of surgery with eyes wide open, reducing the likelihood of post-operative regret.
3. Improving Patient Satisfaction
When a patient is involved in the decision-making process, satisfaction with the surgical outcome typically increases. The study confirms that even when patients choose more complex, higher-risk procedures (like autologous reconstruction), they are generally satisfied if they have been adequately informed of the risks and have weighed those risks against their own personal values.
4. Future Research Directions
The research team is optimistic that this methodology will be adopted by other surgical subspecialties. If the ACBC approach can be successfully integrated into the standard of care for mastectomy patients, it could potentially reduce the "decisional conflict" that leads many patients to feel overwhelmed or coerced during the pre-operative phase.
Conclusion
The study published in Plastic and Reconstructive Surgery provides a clear roadmap for the future of breast reconstruction counseling. By moving away from anecdotal or intuition-based conversations and toward evidence-based, interactive tools, the medical community can ensure that every patient’s values are the cornerstone of their treatment plan.
As Dr. Shammas and his team conclude, the purposeful solicitation of patient values is more than just a procedural improvement—it is a critical requirement for equitable care. In an era where precision medicine is often defined by genetics and technology, the most essential "precision" may be the alignment of surgical options with the personal goals, fears, and values of the individual woman standing in the exam room.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in professional information, software solutions, and services for the healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG sectors. With headquarters in the Netherlands, the group serves customers in over 180 countries, maintaining a workforce of approximately 20,000 people dedicated to helping professionals make critical decisions every day.
For further reading on this study, titled "Preferences for Care among African American Women Considering Postmastectomy Breast Reconstruction" (doi: 10.1097/PRS.0000000000012003), please visit the official Plastic and Reconstructive Surgery journal website.
About the Author
